Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study

被引：39
|
作者：
Uchida, H. [1 ]
Kamata, M. [1 ]
Mizukawa, I. [1 ]
Watanabe, A. [1 ]
Agematsu, A. [1 ]
Nagata, M. [1 ]
Fukaya, S. [1 ]
Hayashi, K. [1 ]
Fukuyasu, A. [1 ]
Tanaka, T. [1 ]
Ishikawa, T. [1 ]
Ohnishi, T. [1 ]
Tada, Y. [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Dermatol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 05期
关键词：
PLACEBO;
D O I：
10.1111/bjd.18163
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1083 / 1085
页数：3
相关论文
共 50 条
  • [1] Real-world effectiveness and safety of nemolizumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study
    Miyawaki, Kayo
    Nakashima, Chisa
    Otsuka, Atsushi
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 691 - 692
  • [2] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
    Kosaka, Keiji
    Uchiyama, Akihiko
    Ishikawa, Mai
    Watanabe, Goichi
    Motegi, Sei-ichiro
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (06) : 800 - 802
  • [3] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
    Keiji Kosaka
    Akihiko Uchiyama
    Mai Ishikawa
    Goichi Watanabe
    Sei-ichiro Motegi
    [J]. European Journal of Dermatology, 2022, 32 : 800 - 802
  • [4] Real-world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single-centre, prospective, open-label study
    Gu, C.
    Wu, Y.
    Luo, Y.
    Wang, S.
    Yin, H.
    Gao, Y.
    Wang, C.
    Yao, X.
    Li, W.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : 1064 - 1073
  • [5] Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study
    Uchiyama, Akihiko
    Fujiwara, Chisako
    Inoue, Yuta
    Motegi, Sei-ichiro
    [J]. JOURNAL OF DERMATOLOGY, 2022, 49 (04): : 469 - 471
  • [6] Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study
    Georgakopoulos, Jorge R.
    Sheka, Dropen
    Rankin, Brian
    Maliyar, Khalad
    Rimke, Alexander
    Prajapati, Vimal H.
    Yeung, Jensen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1308 - 1311
  • [7] Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: A multi centric retrospective study
    Dhar, Sandipan
    De, Abhishek
    Srinivas, Sahana M.
    [J]. INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) : 297 - 301
  • [8] One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study
    Uchida, Hideaki
    Kamata, Masahiro
    Kato, Aika
    Mizukawa, Itsumi
    Watanabe, Ayu
    Agematsu, Ai
    Nagata, Mayumi
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Ishikawa, Takeko
    Ohnishi, Takamitsu
    Tada, Yayoi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (02) : 547 - 550
  • [9] Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study
    Ortoncelli, Michela
    Macagno, Nicole
    Mastorino, Luca
    Gelato, Federica
    Richiardi, Irene
    Cavaliere, Giovanni
    Quaglino, Pietro
    Ribero, Simone
    [J]. COSMETICS, 2023, 10 (06)
  • [10] Real-world effectiveness of dupilumab for the treatment of atopic dermatitis in adult and pediatric patients
    Emmerich, Veronica K.
    Williams, Josiah
    Hrin, Matthew L.
    Newsom, Megan
    Feldman, Steven R.
    Strowd, Lindsay C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB199 - AB199
12345